418 related articles for article (PubMed ID: 30389788)
21. Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis.
Pereira RL; Buscariollo BN; Corrêa-Costa M; Semedo P; Oliveira CD; Reis VO; Maquigussa E; Araújo RC; Braga TT; Soares MF; Moura IC; Malheiros DM; Filho AP; Keller AC; Câmara NO
Kidney Int; 2011 Jun; 79(11):1217-27. PubMed ID: 21412216
[TBL] [Abstract][Full Text] [Related]
22. CALINCA-A Novel Pipeline for the Identification of lncRNAs in Podocyte Disease.
Talyan S; Filipów S; Ignarski M; Smieszek M; Chen H; Kühne L; Butt L; Göbel H; Hoyer-Allo KJR; Koehler FC; Altmüller J; Brinkkötter P; Schermer B; Benzing T; Kann M; Müller RU; Dieterich C
Cells; 2021 Mar; 10(3):. PubMed ID: 33804736
[TBL] [Abstract][Full Text] [Related]
23. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
24. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
Guo N; Guo J; Su D
Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
[TBL] [Abstract][Full Text] [Related]
26. Pathobiology of focal segmental glomerulosclerosis: new developments.
D'Agati VD
Curr Opin Nephrol Hypertens; 2012 May; 21(3):243-50. PubMed ID: 22357339
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes.
Wu J; Zheng C; Wang X; Yun S; Zhao Y; Liu L; Lu Y; Ye Y; Zhu X; Zhang C; Shi S; Liu Z
J Clin Invest; 2015 Nov; 125(11):4091-106. PubMed ID: 26436650
[TBL] [Abstract][Full Text] [Related]
28. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
Kim JS; Han BG; Choi SO; Cha SK
Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
[TBL] [Abstract][Full Text] [Related]
29. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of the long non-coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR-217-TLR4 pathway.
Jin LW; Pan M; Ye HY; Zheng Y; Chen Y; Huang WW; Xu XY; Zheng SB
Exp Physiol; 2019 Feb; 104(2):220-230. PubMed ID: 30414341
[TBL] [Abstract][Full Text] [Related]
31. Role of C/EBP-α in Adriamycin-induced podocyte injury.
Zhong F; Wang W; Lee K; He JC; Chen N
Sci Rep; 2016 Sep; 6():33520. PubMed ID: 27644413
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.
Liu XD; Zhang LY; Zhu TC; Zhang RF; Wang SL; Bao Y
Int J Clin Exp Pathol; 2015; 8(5):4525-34. PubMed ID: 26191142
[TBL] [Abstract][Full Text] [Related]
33. Focal segmental glomerulosclerosis; why does it occur segmentally?
Nagata M; Kobayashi N; Hara S
Pflugers Arch; 2017 Aug; 469(7-8):983-988. PubMed ID: 28664408
[TBL] [Abstract][Full Text] [Related]
34. Rac1 activation in podocytes induces the spectrum of nephrotic syndrome.
Robins R; Baldwin C; Aoudjit L; Côté JF; Gupta IR; Takano T
Kidney Int; 2017 Aug; 92(2):349-364. PubMed ID: 28483380
[TBL] [Abstract][Full Text] [Related]
35. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
Marshall CB; Krofft RD; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
[TBL] [Abstract][Full Text] [Related]
36. Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes.
Barutta F; Kimura S; Hase K; Bellini S; Corbetta B; Corbelli A; Fiordaliso F; Barreca A; Papotti MG; Ghiggeri GM; Salvidio G; Roccatello D; Audrito V; Deaglio S; Gambino R; Bruno S; Camussi G; Martini M; Hirsch E; Durazzo M; Ohno H; Gruden G
J Am Soc Nephrol; 2021 May; 32(5):1114-1130. PubMed ID: 33722931
[TBL] [Abstract][Full Text] [Related]
37. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
[TBL] [Abstract][Full Text] [Related]
38. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
39. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
